Keyphrases
Head-and-neck Cancer
73%
Head-and-neck
68%
Carnitine Deficiency
41%
L-carnitine
41%
Carnitine Supplementation
41%
Treatment Strategy
36%
Oropharynx
34%
Neck Dissection
33%
Locoregional Control
33%
Radiotherapy
27%
5-year Outcomes
27%
Radiation Therapy
27%
Squamous Cell Carcinoma (SqCC)
27%
Squamous Cell Carcinoma of Head
24%
Patient Demographics
24%
Chemotherapy
23%
Chemoradiotherapy
21%
Quality of Life
20%
Karnofsky Performance Status
19%
Cancer Patients
19%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
18%
Local Control
18%
Functional Outcome
18%
Saliva
17%
Low Dose Rate
17%
Squamous Cell Carcinoma of Unknown Primary
17%
Locoregionally Advanced
16%
Primary Radiotherapy
16%
Treatment Outcome
16%
Primary Unknown
16%
Overall Survival
16%
Tolerability
15%
Placebo-controlled Study
15%
Cancer-related Fatigue
15%
Patients with Advanced Cancer
15%
In Cancer
15%
Depressed Mood
15%
Performance Status
15%
Tracheostomy
13%
Phase II Trial
13%
Ongoing Trials
13%
Romidepsin
13%
Orbital Lymphoma
13%
Close Margins
13%
Phase II Study
13%
Treatment Toxicity
13%
Recurrent Metastatic
13%
Symptomatic Outcome
13%
Clinical Trials
13%
Trimodality
13%
Medicine and Dentistry
Neck
100%
Radiation Therapy
83%
Head and Neck Cancer
73%
Squamous Cell Carcinoma
69%
Chemoradiotherapy
57%
Disease
42%
Chemotherapy
35%
Oropharynx
33%
Neck Dissection
33%
Cancer of Unknown Primary Origin
29%
Quality of Life
27%
Patient Population
23%
Neoplasm
20%
Overall Survival
17%
Contralateral
16%
Cancer
16%
Tracheostomy
13%
Orbital Lymphoma
13%
External Auditory Canal
13%
Pleomorphic Adenoma
13%
Clinical Trial
13%
Sinonasal Undifferentiated Carcinoma
13%
Phase II Trials
13%
Histone Deacetylase Inhibitor
13%
Hyposalivation
13%
Tonsil
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Oropharynx Squamous Cell Carcinoma
13%
Romidepsin
13%
Human Immunodeficiency Virus
13%
Head and Neck Squamous Cell Carcinoma
13%
Xerostomia
13%
Malignant Neoplasm
12%
Larynx
11%
Plummer-Vinson Syndrome
11%
Distant Metastasis Free Survival
10%
Distant Metastasis
10%
Histone Deacetylase
9%
Recurrent Disease
9%
Tongue
9%
Disease Free Survival
9%
Intensity Modulated Radiation Therapy
8%
Hypopharynx
8%
Speech Production
7%
Retrospective Study
7%
Nasopharynx
7%
Middle Ear
6%
Temporal Bone
6%
Cisplatin
6%
Parageusia
6%